| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,245 |
4,660 |
$1.26M |
| G0378 |
Hospital observation service, per hour |
1,156 |
942 |
$698K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,308 |
3,719 |
$624K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,182 |
1,732 |
$131K |
| 80053 |
Comprehensive metabolic panel |
9,295 |
7,086 |
$104K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
846 |
706 |
$79K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
187 |
172 |
$75K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,454 |
7,720 |
$47K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,969 |
1,699 |
$29K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,532 |
1,398 |
$24K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
475 |
424 |
$23K |
| 71045 |
Radiologic examination, chest; single view |
2,696 |
2,399 |
$21K |
| 84484 |
|
4,684 |
3,273 |
$21K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,027 |
1,508 |
$13K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
457 |
395 |
$12K |
| J3490 |
Unclassified drugs |
1,211 |
756 |
$10K |
| 81001 |
|
3,391 |
2,872 |
$9K |
| 87040 |
|
564 |
278 |
$8K |
| 85610 |
|
4,541 |
4,075 |
$7K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
216 |
194 |
$7K |
| 83690 |
|
2,898 |
2,586 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
681 |
555 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,364 |
2,528 |
$5K |
| 83735 |
|
3,743 |
2,992 |
$5K |
| 87631 |
|
169 |
160 |
$4K |
| A9270 |
Non-covered item or service |
13,870 |
3,506 |
$4K |
| 85730 |
|
2,577 |
2,411 |
$4K |
| 82962 |
|
2,565 |
917 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
408 |
234 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
1,399 |
1,033 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
431 |
270 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,898 |
1,655 |
$2K |
| 84703 |
|
188 |
159 |
$2K |
| 85027 |
|
1,295 |
1,010 |
$2K |
| 82077 |
|
140 |
123 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
642 |
497 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,210 |
1,782 |
$2K |
| 86850 |
|
83 |
60 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,428 |
893 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
705 |
584 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
490 |
431 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
164 |
151 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,252 |
1,091 |
$922.16 |
| 83605 |
|
791 |
657 |
$919.85 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
676 |
632 |
$801.73 |
| 71046 |
Radiologic examination, chest; 2 views |
62 |
57 |
$784.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
340 |
272 |
$733.90 |
| 83880 |
|
209 |
196 |
$604.65 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
63 |
54 |
$554.75 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
762 |
662 |
$517.76 |
| J1644 |
Injection, heparin sodium, per 1000 units |
64 |
37 |
$457.02 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
142 |
111 |
$381.48 |
| 90715 |
|
26 |
24 |
$303.88 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
31 |
25 |
$303.32 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
56 |
53 |
$249.66 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
84 |
51 |
$156.02 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
50 |
37 |
$143.10 |
| C1769 |
Guide wire |
31 |
26 |
$130.62 |
| 82150 |
|
28 |
25 |
$74.88 |
| 86901 |
|
42 |
41 |
$61.45 |
| 86900 |
|
42 |
41 |
$61.45 |
| J1815 |
Injection, insulin, per 5 units |
19 |
13 |
$42.79 |
| 80061 |
Lipid panel |
13 |
12 |
$35.03 |
| 84132 |
|
384 |
350 |
$22.31 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
127 |
123 |
$0.00 |
| 82435 |
|
206 |
185 |
$0.00 |
| 97162 |
|
29 |
26 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$0.00 |
| 84295 |
|
229 |
201 |
$0.00 |
| 82947 |
|
198 |
177 |
$0.00 |
| 85014 |
|
217 |
193 |
$0.00 |
| 84520 |
|
205 |
184 |
$0.00 |
| 82565 |
|
223 |
200 |
$0.00 |
| G1012 |
Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program |
185 |
130 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
34 |
26 |
$0.00 |